Investigation of Sensitivity and Specificity in Pripoinibacterium Acnes Specific Monoclonal Antibodies of Cardiac Sarcoidosis
Not Applicable
Completed
- Conditions
- Cardiac Sarcoidosis
- Registration Number
- JPRN-UMIN000010141
- Lead Sponsor
- Hokkaido university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
We excluded the patients, we couldn't obtain the consent, we couldn't perform endomyocardial biopsy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity of PAB antibody in cardiac sarcoidosis
- Secondary Outcome Measures
Name Time Method We compared sensitivity and specificity of PAB antibady with cardiac sarcoidosis and the other heart disease.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie P. acnes-specific monoclonal antibody detection in cardiac sarcoidosis?
How do P. acnes-specific monoclonal antibodies compare to standard diagnostic methods for cardiac sarcoidosis?
Which biomarkers correlate with antibody response in cardiac sarcoidosis subtypes linked to P. acnes infection?
What adverse events are associated with P. acnes-targeting monoclonal antibody therapies in autoimmune diseases?
Are there combination therapies involving P. acnes-specific antibodies for sarcoidosis beyond Hokkaido University's trial?